Drug intelligence / Profile preview

Flukodin

Development stage: Unknown
Lead developer: Arosol Pharmaceuticals

Overview

Flukodin is a veterinary herbal and nutritional supplement developed by Arosol Pharmaceuticals, a subsidiary of Nutricare Life Sciences Limited. Formulated using Ayurvedic and phytogenic principles, it is designed as a supportive health product for a wide range of animals, including livestock, poultry, pets, and aquatic species. As a herbal formulation, it typically contains a blend of plant-derived bioactive compounds intended to enhance physiological functions, support immunity, and improve overall animal well-being and productivity. It is positioned as a natural alternative or adjunct to traditional veterinary pharmaceuticals, focusing on nutritional support rather than targeted molecular drug action.

Brand names: Flukodin
Other names: Flukodin-Arosol

Beyond the preview

Go deeper on Flukodin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flukodin.

Explore the full profile